I 
119TH CONGRESS 
2D SESSION 
H. R. 6993 
To direct the Secretary of Veterans Affairs to carry out programs to award 
grants to eligible entities to conduct research with respect to treatments 
for traumatic brain injury prospective randomized control trials for 
neurorehabilitation treatments, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
JANUARY 9, 2026 
Mr. BERGMAN (for himself, Ms. ELFRETH, Ms. KING-HINDS, Mr. DAVIS of 
North Carolina, Mr. VAN ORDEN, and Mr. LUTTRELL) introduced the 
following bill; which was referred to the Committee on Veterans’ Affairs 
A BILL 
To direct the Secretary of Veterans Affairs to carry out 
programs to award grants to eligible entities to conduct 
research with respect to treatments for traumatic brain 
injury 
prospective 
randomized 
control 
trials 
for 
neurorehabilitation treatments, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Veterans TBI Break-
through Exploration of Adaptive Care Opportunities Na-
tionwide Act of 2026’’ or the ‘‘BEACON Act of 2026’’. 
VerDate Sep 11 2014 
19:56 Jan 21, 2026
Jkt 069200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H6993.IH
H6993
ssavage on LAPJG3WLY3PROD with BILLS
SEC. 2. DEPARTMENT OF VETERANS AFFAIRS GRANT PRO-
GRAM 
FOR 
SUPPLEMENTAL 
NEUROREHABILITATION 
APPROACHES 
TO 
CHRONIC MILD TBI TREATMENT. 
(a) IN GENERAL.—The Secretary of Veterans Affairs 
shall establish a grant program (to be known as the ‘‘TBI 
Innovation Grant Program’’) to award grants to eligible 
entities described in subsection (b) for the development, 
implementation, and evaluation of approaches and meth-
odologies for prospective randomized control trials for 
neurorehabilitation treatments for the treatment of chron-
ic mild TBI (mTBI) in veterans. 
(b) ELIGIBLE ENTITIES DESCRIBED.—An eligible 
entity described in this subsection is any of the following: 
(1) A nonprofit organization. 
(2) An academic institution engaged in research 
with respect to TBI. 
(3) A non-Department health care provider with 
expertise in neurorehabilitative therapies. 
(4) An entity the Secretary determines appro-
priate for an award of a grant under this section. 
(c) USE OF FUNDS.—An eligible entity in receipt of 
a grant under this section shall use such grant to support 
activities that include— 
VerDate Sep 11 2014 
19:56 Jan 21, 2026
Jkt 069200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H6993.IH
H6993
ssavage on LAPJG3WLY3PROD with BILLS
(1) designing and testing novel or integrative 
treatments for mTBI that prioritize patient-centered 
care, including non-pharmacological therapies; 
(2) conducting clinical studies and assessments 
to measure the effectiveness of funded approaches 
to— 
(A) 
improve 
mental 
health 
outcomes 
among veterans; 
(B) reduce suicidality, and common risk 
factors for completing suicide, including depres-
sion and substance use disorders among vet-
erans; and 
(C) mitigate long-term effects of mTBI; 
(3) providing training for clinicians and out-
reach to veterans and their families to improve 
awareness and accessibility of innovative mTBI 
treatments; and 
(4) establishing partnerships with community 
organizations, academic institutions, and health care 
facilities of the Department of Veterans Affairs to 
implement and evaluate best practices. 
(d) LIMITATION ON GRANT AMOUNT.—The Secretary 
may not award an eligible entity a grant under this section 
in an amount that exceeds $5,000,000 per fiscal year. 
VerDate Sep 11 2014 
19:56 Jan 21, 2026
Jkt 069200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H6993.IH
H6993
ssavage on LAPJG3WLY3PROD with BILLS